Woodbois Valuation
Is OB7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OB7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate OB7's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate OB7's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OB7?
Key metric: As OB7 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is OB7's PS Ratio? | |
|---|---|
| PS Ratio | 1.6x |
| Sales | US$6.72m |
| Market Cap | US$10.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2x |
| Enterprise Value/EBITDA | -3.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does OB7's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
DLX Delignit | 0.3x | 10.2% | €23.4m |
BIG1 Bio-Gate | 0.8x | 16.3% | €6.5m |
CFF Conifex Timber | 0.1x | n/a | CA$17.3m |
TIMWELL Timberwell Berhad | 2.1x | n/a | RM 47.6m |
OB7 Woodbois | 1.6x | n/a | €8.3m |
Price-To-Sales vs Peers: OB7 is expensive based on its Price-To-Sales Ratio (1.6x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does OB7's PS Ratio compare vs other companies in the European Forestry Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: OB7 is expensive based on its Price-To-Sales Ratio (1.6x) compared to the European Forestry industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is OB7's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.6x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate OB7's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.85
7D
0.4%
1Y
-19.9%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
Mitsubishi Chemical Group
JP¥1.1t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥4.77
7D
-4.3%
1Y
-20.5%